On March 29, 2024, Charles River Laboratories International, Inc announced that it has received a shareholder proposal from People for the Ethical Treatment of Animals (PETA) requesting Board shall report to shareholders annually on the species, provenance (including country of origin and wild-caught or captive-bred status), and numbers of nonhuman primates imported by our company into the U.S.; the company?s procedures to screen for and report the presence of zoonotic disease among these animals; and measures taken by the company to mitigate the impact of such importation on the dwindling populations of these primates in nature, omitting proprietary information. In addition, the board has recommended shareholders to vote against this proposal at the 2024 Annual Meeting to be held on May 8, 2024.